Skip to main content

Pregnancy Related

5
Pipeline Programs
30
Companies
42
Clinical Trials
8 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
1
2
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

28 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
3 programs
1
1
Standard Dose of Unfractionated HeparinPhase 41 trial
MWSH plus Candlelit CarePhase 2/31 trial
Cognitive Behavioral Stress ManagementN/A1 trial
Active Trials
NCT03627247Completed100Est. Aug 2014
NCT05552053Active Not Recruiting150Est. Jun 2027
NCT04635839Completed46Est. May 2022
Human BioSciences
Human BioSciencesWV - Martinsburg
7 programs
2
0 to 20 tablets of oxycodone 5mgPhase 31 trial
Ferumoxytol Injection [Feraheme]Phase 31 trial
EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)N/A
Informed free choiceN/A1 trial
Pilot Study to Investigate Dietary Changes During PregnancyN/A1 trial
+2 more programs
Active Trials
NCT00505596Completed744Est. Jan 2013
NCT06095232Unknown156Est. Aug 2025
NCT04430439Completed113Est. Feb 2024
+3 more trials
UNION therapeutics
1
EnoxaparinPhase 21 trial
Chinese Pregnant Woman Cohort StudyN/A1 trial
Chinese Pregnant Woman Cohort Study (Offspring Follow-up)N/A1 trial
Active Trials
NCT03403543Unknown5,000Est. Dec 2019
NCT04444791Unknown1,978Est. Dec 2020
NCT06531525Not Yet Recruiting48Est. Dec 2027
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
4 programs
Telehealth VisitN/A1 trial
Wearable Activity TrackerN/A1 trial
eDoula AppN/A1 trial
evidence-based labor guideN/A1 trial
Active Trials
NCT05848908Completed50Est. Jun 2025
NCT07331909Not Yet Recruiting40Est. Jul 2026
NCT06785467Recruiting60Est. Jun 2026
+1 more trials
Philips
PhilipsNetherlands - Amsterdam
2 programs
3D volume acquisitionsN/A1 trial
Non-diagnostic software solutionN/A1 trial
Active Trials
NCT03812471Completed265Est. Mar 2023
NCT04243369Completed30Est. Feb 2020
Biorithm
2 programs
AMBulatory Fetal ECG Monitoring in Low and High-Risk PregnanciesN/A1 trial
Femom System Compared to the Standard of Care CTGN/A1 trial
Active Trials
NCT06497205Recruiting180Est. Aug 2025
NCT06490471Not Yet Recruiting120Est. Jul 2025
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
2 programs
EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)N/A1 trial
Microbiome and Malnutrition in PregnancyN/A1 trial
Active Trials
NCT01209754Completed873Est. May 2020
NCT04992104Active Not Recruiting800Est. Mar 2027
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
2 programs
In-Utero Vascular Accidents in Neonates From COVID-19 Infected MothersN/A1 trial
The Sleep in Pregnancy StudyN/A1 trial
Active Trials
NCT04431869Completed215Est. Sep 2021
NCT03248219Completed19Est. Mar 2018
Incyte
IncyteDE - Wilmington
2 programs
Ruxolitinib CreamN/A1 trial
Ruxolitinib CreamN/A1 trial
Active Trials
NCT06259669Recruiting958Est. Aug 2033
NCT06627335Recruiting5,621Est. Aug 2028
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Alternate Nostril BreathingN/A1 trial
Active Trials
NCT05341921CompletedEst. Dec 2024
Cognition Therapeutics
Cognition TherapeuticsPA - Pittsburgh
1 program
Better Understanding the Metamorphosis of Pregnancy (BUMP)N/A1 trial
Active Trials
NCT04714905Completed712Est. Jul 2023
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
COHN/A1 trial
Active Trials
NCT05499507Recruiting432Est. Dec 2028
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
Chama cha MamaTotoN/A1 trial
Active Trials
NCT03187873Unknown3,040Est. Dec 2018
Purdue Pharma
Purdue PharmaCT - Stamford
1 program
Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and PostpartumN/A1 trial
Active Trials
NCT05504889Completed36Est. Jun 2023
Illumina
IlluminaCA - Hayward
1 program
Collection of Whole Blood Specimens in Pregnant WomenN/A1 trial
Active Trials
NCT03590678Completed3,000Est. Dec 2019
Bionexus
BionexusCA - Oakland
1 program
Doula CareN/A
Shield Therapeutics
Shield TherapeuticsMA - Wellesley
1 program
Doula CareN/A1 trial
Active Trials
NCT07157059Completed30Est. Nov 2024
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Elective InductionN/A1 trial
Active Trials
NCT04597528Completed315Est. May 2021
Design Pharmaceuticals
1 program
Fourth Trimester Mobile ToolN/A
Design Therapeutics
1 program
Fourth Trimester Mobile ToolN/A1 trial
Active Trials
NCT04475718Completed87Est. Dec 2021
Pattern Pharma
Pattern PharmaON - Toronto
1 program
GROWellN/A1 trial
Active Trials
NCT04449432Completed480Est. Jun 2024
March Biosciences
March BiosciencesTX - Houston
1 program
Informed free choiceN/A
Young BioPharma
Young BioPharmaMA - Lowell
1 program
Low tech health SMS messagesN/A1 trial
Active Trials
NCT05022277Unknown2,000Est. Oct 2021
GE HealthCare
1 program
Novii ECG/EKG SystemN/A1 trial
Active Trials
NCT03156608Completed218Est. Jun 2017
Harmony Biosciences
Harmony BiosciencesPLYMOUTH MEETING, PA
1 program
PitolisantN/A1 trial
Active Trials
NCT05536011Recruiting1,329Est. Jun 2030
Innovation Pharmaceuticals
1 program
TeamBaby Online Communication TrainingN/A1 trial
Active Trials
NCT03855735Completed424Est. Mar 2023
Alliance Pharmaceuticals
1 program
The Heartland StudyN/A1 trial
Active Trials
NCT05492708Recruiting2,600Est. Jan 2029
Bioserenity
BioserenityFrance - Paris
1 program
cardiotocographN/A1 trial
Active Trials
NCT03444909Completed35Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Angeles TherapeuticsStandard Dose of Unfractionated Heparin
Human BioSciencesFerumoxytol Injection [Feraheme]
Human BioSciences0 to 20 tablets of oxycodone 5mg
Angeles TherapeuticsMWSH plus Candlelit Care
UNION therapeuticsEnoxaparin
Oregon TherapeuticsWearable Activity Tracker
Oregon Therapeuticsevidence-based labor guide
Oregon TherapeuticseDoula App
BiorithmFemom System Compared to the Standard of Care CTG
BiorithmAMBulatory Fetal ECG Monitoring in Low and High-Risk Pregnancies
IncyteRuxolitinib Cream
Human BioSciencesPilot Study to Investigate Dietary Changes During Pregnancy
Oregon TherapeuticsTelehealth Visit
Shield TherapeuticsDoula Care
IncyteRuxolitinib Cream

Showing 15 of 42 trials with date data

Clinical Trials (42)

Total enrollment: 38,191 patients across 42 trials

NCT04635839Angeles TherapeuticsStandard Dose of Unfractionated Heparin

Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)

Start: Dec 2020Est. completion: May 202246 patients
Phase 4Completed
NCT04253626Human BioSciencesFerumoxytol Injection [Feraheme]

Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia

Start: Jan 2021Est. completion: Jul 202483 patients
Phase 3Completed
NCT04296396Human BioSciences0 to 20 tablets of oxycodone 5mg

Opioid Prescription After Cesarean Trial

Start: Sep 2020Est. completion: Jul 20225,521 patients
Phase 3Completed
NCT05552053Angeles TherapeuticsMWSH plus Candlelit Care

Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women

Start: Jun 2023Est. completion: Jun 2027150 patients
Phase 2/3Active Not Recruiting

Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency

Start: Aug 2024Est. completion: Dec 202748 patients
Phase 2Not Yet Recruiting
NCT07331909Oregon TherapeuticsWearable Activity Tracker

Assessing the Use of Wearable Activity Trackers in a Pregnancy Cohort

Start: Jan 2026Est. completion: Jul 202640 patients
N/ANot Yet Recruiting
NCT06787521Oregon Therapeuticsevidence-based labor guide

Patient Empowerment and Agency Through Intrapartum Counseling and Education

Start: Apr 2025Est. completion: Dec 2025204 patients
N/ARecruiting

eDoula Feasibility and Acceptability

Start: Jan 2025Est. completion: Jun 202660 patients
N/ARecruiting
NCT06490471BiorithmFemom System Compared to the Standard of Care CTG

Femom System Compared to the Standard of Care CTG

Start: Jul 2024Est. completion: Jul 2025120 patients
N/ANot Yet Recruiting
NCT06497205BiorithmAMBulatory Fetal ECG Monitoring in Low and High-Risk Pregnancies

AMBulatory Fetal ECG Monitoring in Low and High-Risk Pregnancies

Start: Mar 2024Est. completion: Aug 2025180 patients
N/ARecruiting
NCT06259669IncyteRuxolitinib Cream

Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

Start: Sep 2023Est. completion: Aug 2033958 patients
N/ARecruiting
NCT06095232Human BioSciencesPilot Study to Investigate Dietary Changes During Pregnancy

Pilot Study to Investigate Dietary Changes During Pregnancy

Start: Aug 2023Est. completion: Aug 2025156 patients
N/AUnknown

Advanced Provision of Care

Start: Jun 2023Est. completion: Jun 202550 patients
N/ACompleted

Labor and Delivery Doula Program to Reduce Perinatal Morbidity and Mortality in Kansas

Start: May 2023Est. completion: Nov 202430 patients
N/ACompleted
NCT06627335IncyteRuxolitinib Cream

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

Start: Mar 2023Est. completion: Aug 20285,621 patients
N/ARecruiting
NCT04992104Allergy TherapeuticsMicrobiome and Malnutrition in Pregnancy

Microbiome and Malnutrition in Pregnancy

Start: Feb 2023Est. completion: Mar 2027800 patients
N/AActive Not Recruiting

The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)

Start: Jan 2023Est. completion: Dec 2028432 patients
N/ARecruiting
NCT05341921City TherapeuticsAlternate Nostril Breathing

Deep Breathing Techniques (Pranayama) in Pregnancy

Start: Aug 2022Est. completion: Dec 2024
N/ACompleted
NCT05504889Purdue PharmaCholesterol and CYP3A4/5 Metabolism Across Pregnancy and Postpartum

Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and Postpartum

Start: Jun 2022Est. completion: Jun 202336 patients
N/ACompleted

WAKIX® (Pitolisant) Pregnancy Registry

Start: Aug 2021Est. completion: Jun 20301,329 patients
N/ARecruiting
NCT04475718Design TherapeuticsFourth Trimester Mobile Tool

Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women

Start: May 2021Est. completion: Dec 202187 patients
N/ACompleted
NCT04430439Human BioSciencesPsychosocial stress

Emotion-Diet Interactions in Pregnancy

Start: May 2021Est. completion: Feb 2024113 patients
N/ACompleted

The Stony Brook University Calm-Mom Study

Start: Apr 2021Est. completion: Jun 202379 patients
N/ACompleted
NCT04714905Cognition TherapeuticsBetter Understanding the Metamorphosis of Pregnancy (BUMP)

Better Understanding the Metamorphosis of Pregnancy (BUMP)

Start: Feb 2021Est. completion: Jul 2023712 patients
N/ACompleted

Goals for Reaching Optimal Wellness: GROWell

Start: Dec 2020Est. completion: Jun 2024480 patients
N/ACompleted
NCT04431869Colorado TherapeuticsIn-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers

In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers

Start: Aug 2020Est. completion: Sep 2021215 patients
N/ACompleted
NCT04444791UNION therapeuticsChinese Pregnant Woman Cohort Study (Offspring Follow-up)

Chinese Pregnant Woman Cohort Study (Offspring Follow-up)

Start: Aug 2020Est. completion: Dec 20201,978 patients
N/AUnknown
NCT05022277Young BioPharmaLow tech health SMS messages

Empowering Girls: Health-seeking Behavior, Staying in School, and Preventing Risky Sex

Start: Apr 2020Est. completion: Oct 20212,000 patients
N/AUnknown

The Heartland Study

Start: Jan 2020Est. completion: Jan 20292,600 patients
N/ARecruiting
NCT04243369PhilipsNon-diagnostic software solution

Collaboration Live

Start: Jan 2020Est. completion: Feb 202030 patients
N/ACompleted

Elective Induction of Labour at Thirty Nine Weeks: a Prospective Observational Study

Start: Oct 2019Est. completion: May 2021315 patients
N/ACompleted
NCT03855735Innovation PharmaceuticalsTeamBaby Online Communication Training

TeamBaby - Safe, Digitally Supported Communication in Obstetrics and Gynecology

Start: Sep 2019Est. completion: Mar 2023424 patients
N/ACompleted
NCT03444909Bioserenitycardiotocograph

Collection of Information by Tocography External

Start: Dec 2018Est. completion: Dec 201935 patients
N/ACompleted
NCT03812471Philips3D volume acquisitions

Optimization of Fetal Biometry With 3D Ultrasound and Image Recognition

Start: Oct 2018Est. completion: Mar 2023265 patients
N/ACompleted
NCT03403543UNION therapeuticsChinese Pregnant Woman Cohort Study

Chinese Pregnant Woman Cohort Study

Start: Jul 2017Est. completion: Dec 20195,000 patients
N/AUnknown
NCT03187873AbbVieChama cha MamaToto

Chamas for Change Validation

Start: May 2017Est. completion: Dec 20183,040 patients
N/AUnknown
NCT03248219Colorado TherapeuticsThe Sleep in Pregnancy Study

The Sleep in Pregnancy Study

Start: Mar 2017Est. completion: Mar 201819 patients
N/ACompleted
NCT03156608GE HealthCareNovii ECG/EKG System

Novii External Fetal Monitoring Device

Start: Mar 2017Est. completion: Jun 2017218 patients
N/ACompleted
NCT03590678IlluminaCollection of Whole Blood Specimens in Pregnant Women

Collection of Whole Blood Specimens in Pregnant Women

Start: Feb 2017Est. completion: Dec 20193,000 patients
N/ACompleted
NCT03627247Angeles TherapeuticsCognitive Behavioral Stress Management

Impact of Stress Management on Cortisol Patterns in Low-Income Pregnant Women

Start: Dec 2010Est. completion: Aug 2014100 patients
N/ACompleted
NCT01209754Allergy TherapeuticsEMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Start: Oct 2009Est. completion: May 2020873 patients
N/ACompleted
NCT00505596Human BioSciencesInformed free choice

Expanded Prenatal Testing Options and Informed Choice

Start: Dec 2007Est. completion: Jan 2013744 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
8 actively recruiting trials targeting 38,191 patients
30 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.